Zentalis Pharmaceuticals Appoints Kimberly Freeman as Chief Strategy Officer

Go back to Zentalis Pharmaceuticals Appoints Kimberly Freeman as Chief Strategy Officer
(NASDAQ: ZNTL) Delayed: 3.82 --0 (-0%)
Previous Close $3.82    52 Week High
Open $3.82    52 Week Low
Day High $3.82    P/E N/A 
Day Low $3.82    EPS
Volume 17,180